GSA Capital Partners’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

GSA Capital Partners’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,915	Closed	-$332K	–	1327
2020 Q1	$332K	Buy	+6,915	New	+$322K	0.08%	421

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

GSA Capital Partners's RARX Position: Q2 2020 in Review

GSA Capital Partners sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 6,915 shares — an estimated $332K sold.

GSA Capital Partners first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $332K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

GSA Capital Partners reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
GSA Capital Partners sold 6,915 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $332K.
GSA Capital Partners first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
GSA Capital Partners's Ra Pharmaceuticals, Inc. Common Stock position peaked at $332K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on GSA Capital Partners's 13F filing for Q2 2020, filed 11 Aug 2020.